Trial Profile
Phase I Study of CellCept for Advanced Pancreatic Cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Feb 2013
Price :
$35
*
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions
- 27 Oct 2009 New trial record